Toggle navigation
News
OK
NewsOK
News
Weather
Opinion
Business
Sports
Life
Photos
Videos
Brandinsight
Shopping
Classifieds
Homes
Jobs
Cars
Legals
Shop
Account
Settings
Subscribe
Contact Us
Support
Privacy Policy
Terms of Use
About our ads
Advertise with us
The Oklahoman
Market Watch
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Local Stocks
NewsOK Local Stocks
NewsOK Local Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Moderna Inc
(NQ:
MRNA
)
156.79
+8.41 (+5.67%)
Streaming Delayed Price
Updated: 11:35 AM EST, Feb 26, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Moderna Inc
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Moderna Has Completed Case Accrual for First Planned Interim Analysis of its mRNA Vaccine Against COVID-19 (mRNA-1273)
November 11, 2020
Moderna has completed case accrual for first planned interim analysis of its mRNA vaccine against COVID-19 (mRNA-1273).
From
Business Wire News Releases
Should you invest in American Airlines, Microsoft, Plug Power, Sorrento Therapeutics, or Moderna?
November 11, 2020
InvestorsObserver issues critical PriceWatch Alerts for AAL, MSFT, PLUG, SRNE, and MRNA.
From
PR Newswire
Moderna Announces Clinical Updates on Personalized Cancer Vaccine Program
November 11, 2020
Moderna announces clinical updates on Personalized Cancer Vaccine program
From
Business Wire News Releases
Covid-19 Resurgence Leading to Increasing Demand For Automated UV-C Light-Based Surface Disinfection Systems
November 04, 2020
Tags
Featured News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Covid-19 Resurgence Leading to Increasing Demand For Automated UV-C Light-Based Surface Disinfection Systems
November 04, 2020
Financialnewsmedia.com News Commentary
From
PR Newswire
2nd Annual Gabelli Funds – Columbia Business School Healthcare Symposium (Virtual) – Friday, November 13, 2020
November 02, 2020
Join us as we discuss today’s pressing healthcare issues.
From
Business Wire News Releases
Vaccine Development Holdups Reinforce the Need for Interim Solutions
November 02, 2020
FinancialBuzz.com News Commentary
From
PR Newswire
Moderna to Present at Upcoming Investor Conferences in November 2020
November 02, 2020
Moderna to present at upcoming investor conferences in November 2020.
From
Business Wire News Releases
Moderna Named Top Employer by Science for Sixth Consecutive Year
October 30, 2020
Moderna named top employer by Science for sixth consecutive year.
From
Business Wire News Releases
Thinking about trading options or stock in Moderna, Nio, Overstock.com, Marvell Technology, or Walt Disney?
October 29, 2020
InvestorsObserver issues critical PriceWatch Alerts for MRNA, NIO, OSTK, MRVL, and DIS.
From
PR Newswire
Moderna Reports Third Quarter 2020 Financial Results and Provides Business Updates
October 29, 2020
Moderna reports third quarter 2020 financial results and provides business updates.
From
Business Wire News Releases
Moderna Partners with Takeda and the Government of Japan to Supply 50 Million Doses of mRNA Vaccine Against COVID-19 (mRNA-1273) to Japan
October 29, 2020
Moderna partners with Takeda and the government of Japan to supply 50 million doses of mRNA vaccine against COVID-19 (mRNA-1273) to Japan.
From
Business Wire News Releases
UVC Radiation Devices & Disinfection Solutions Playing Major Role in Barrier Approach for Reducing Viruses
October 28, 2020
Financialnewsmedia.com News Commentary
From
PR Newswire
UVC Radiation Devices & Disinfection Solutions Playing Major Role in Barrier Approach for Reducing Viruses
October 28, 2020
Tags
Featured News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
UK Medicines and Healthcare products Regulatory Agency Begins Rolling Review of Moderna’s mRNA Vaccine Against COVID-19 (mRNA-1273)
October 27, 2020
UK Medicines and Healthcare products Regulatory Agency begins rolling review of Moderna’s mRNA vaccine against COVID-19 (mRNA-1273).
From
Business Wire News Releases
As Essential Covid-19 Treatments and Services Become More Needed, Healthcare Cloud Computing Is Booming
October 27, 2020
Tags
Featured News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
As Essential Covid-19 Treatments and Services Become More Needed, Healthcare Cloud Computing Is Booming
October 27, 2020
Financialnewsmedia.com News Commentary
From
PR Newswire
Thinking about trading options or stock in Apple, Boeing, Moderna, ServiceNow, or Zoom Video?
October 26, 2020
InvestorsObserver issues critical PriceWatch Alerts for AAPL, BA, MRNA, NOW, and ZM.
From
PR Newswire
Moderna Announces Supply Agreement with the Ministry of Public Health to Supply Qatar with mRNA Vaccine Against COVID-19 (mRNA-1273)
October 26, 2020
Moderna announces supply agreement with the Ministry of Public Health to supply Qatar with mRNA vaccine against COVID-19 (mRNA-1273)
From
Business Wire News Releases
Thinking about trading options or stock in Moderna, General Electric, Walt Disney, F5 Networks, or Capital One?
October 23, 2020
InvestorsObserver issues critical PriceWatch Alerts for MRNA, GE, DIS, FFIV, and COF.
From
PR Newswire
Moderna Completes Enrollment of Phase 3 COVE Study of mRNA Vaccine Against COVID-19 (mRNA-1273)
October 22, 2020
Moderna completes enrollment of Phase 3 COVE study of mRNA vaccine against COVID-19 (mRNA-1273).
From
Business Wire News Releases
Thinking about trading options or stock in Moderna, Procter & Gamble, Microsoft, AT&T, or NVIDIA?
October 20, 2020
InvestorsObserver issues critical PriceWatch Alerts for MRNA, PG, MSFT, T, and NVDA.
From
PR Newswire
2nd Annual Gabelli Funds – Columbia Business School Healthcare Symposium (Virtual)
October 19, 2020
Join us as we discuss today’s pressing healthcare issues.
From
Business Wire News Releases
Moderna to Report Third Quarter 2020 Financial Results on Thursday, October 29, 2020
October 15, 2020
Moderna to report third quarter 2020 financial results on Thursday, October 29, 2020.
From
Business Wire News Releases
Moderna Receives Confirmation of Eligibility for Submission of Marketing Authorization Application to the European Medicines Agency for mRNA Vaccine Against COVID-19 (mRNA-1273)
October 14, 2020
Moderna receives confirmation of eligibility for submission of Marketing Authorization Application to the European Medicines Agency for mRNA-1273.
From
Business Wire News Releases
Moderna Announces Initiation of Rolling Submission to Health Canada for mRNA Vaccine Against COVID-19 (mRNA-1273)
October 13, 2020
Moderna announces initiation of rolling submission to Health Canada for mRNA vaccine against COVID-19 (mRNA-1273)
From
Business Wire News Releases
Thinking about trading options or stock in Xilinx, Moderna, NXP Semiconductors, Carnival Corp, or MGM Resorts?
October 09, 2020
InvestorsObserver issues critical PriceWatch Alerts for XLNX, MRNA, NXPI, CCL, and MGM.
From
PR Newswire
The Evolution of Diagnostic Capabilities Underscores the Fight Against Viral Infections
October 08, 2020
FinancialBuzz.com News Commentary
From
PR Newswire
DARPA Awards Moderna up to $56 Million to Enable Small-Scale, Rapid Mobile Manufacturing of Nucleic Acid Vaccines and Therapeutics
October 08, 2020
DARPA awards Moderna up to $56 million to enable small-scale, rapid mobile manufacturing of nucleic acid vaccines and therapeutics.
From
Business Wire News Releases
Moderna Announces Updates on Respiratory Syncytial Virus (RSV) Vaccine Program
October 08, 2020
Moderna announces updates on respiratory syncytial virus (RSV) vaccine program.
From
Business Wire News Releases
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.